GreenBank Launches MarijuanaForCanada.ca Website

Toronto, Ontario, April 28, 2014 – GreenBank Capital Inc (CNSX: GBC) (“GreenBank”) announces that it has launched a new website www.MarijuanaForCanada.ca aimed at the medical marijuana market.

“MarijuanaForCanada.ca will seek to be the premier Canadian website for the marijuana space. It contains general information about the plant and its medicinal attributes, the latest medical marijuana news, a section on how to find a grower, a section on how to find a doctor, a section for investors in Canadian marijuana public companies, a section to ask questions of our resident expert, and a section for marijuana literature.” commented Danny Wettreich, CEO of GreenBank.

The MarijuanaForCanada expert who will be responding to questions from the public is Dr Stefan A Hulea who is GreenBank’s medical marijuana consultant. Dr. Hulea is currently authoring a book that highlights the pain alleviation properties of medical marijuana as well as health matters directed at the general public. He has an extensive background in biochemistry and worked for over 25 years in basic and applied biomedical research. He graduated from the University of Bucharest, Romania with a B.Sc.(Hon) in Biochemistry and completed his graduate work in the Department of Biochemistry, King’s College London, England, where he earned a Ph.D. in Biochemistry.

Additional features will continue to be added to the website with the aim of providing the Canadian medical marijuana community with a premier web based information source.

About GreenBank

GreenBank is a corporate finance investment business investing in the medical marijuana space, bitcoin startups, and Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. GreenBank also owns www.MarijuanaForCanada.ca a web based information source for the Canadian medical marijuana industry. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Engages Medical Marijuana Consultant

Toronto, Ontario, April 22, 2014 – GreenBank Capital Inc (CNSX: GBC) (“GreenBank”) announces that it has engaged Dr Stefan A Hulea as medical marijuana consultant. Dr Hulea will provide medical marijuana consulting services with respect to the most appropriate marijuana plants and primary growing processes to be utilized in order to maximize the profit potential inherent in the proposed growing operations of GreenBank’s subsidiary Canada Marijuana Agricorp.

Dr. Hulea is currently authoring a book that highlights the pain alleviation properties of medical marijuana as well as health matters directed at the general public. He has an extensive background in biochemistry and worked for over 25 years in basic and applied biomedical research. He graduated from the University of Bucharest, Romania with a B.Sc.(Hon) in Biochemistry and completed his graduate work in the Department of Biochemistry, King’s College London, England, where he earned a Ph.D. in Biochemistry.

Dr. Hulea has published dozens of research papers on a variety of topics including medical marijuana as well as microbial nucleic acids metabolism, the role of complex carbohydrate-binding proteins (lectins) as mediators of host-pathogen interactions, oxidative stress and antioxidant mechanisms in plant and animal cells. In the field of applied research Dr. Hulea took part in the development of a plant extract that was used with very good results in the treatment of severe skin burns as well as some skin disorders. Dr. Hulea was previously a visiting scholar at the University of Illinois at Urbana-Champaign where he conducted research on the molecular mechanisms in cardiovascular disease.

Pursuant to his medical marijuana consulting services, Dr Hulea has been granted a common share purchase warrant entitling the holder to acquire 100,000 common shares at an exercise price of $0.125 per share for 24 months, provided however that in the event that the common shares trade on the CSE at a closing price of greater than $0.50 per share for a period of 5 consecutive trading days the Company may, in its sole discretion, accelerate the expiration date of the warrants.

“Dr Hulea has a distinguished career and his expertise will provide us with unique guidance as our medical marijuana plans evolve” said Danny Wettreich, CEO of GreenBank.

About GreenBank

GreenBank is a corporate finance investment business investing in Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

GreenBank Targets Medical Marijuana Business

New subsidiary Canada Marijuana Agricorp Inc intends to apply for medical marijuana producer license

Toronto, Ontario, April 14, 2014 – GreenBank Capital Inc. (CSE: GBC) (“GreenBank” or “the Company”), announces that it has determined to enter the medical marijuana business and has established a new subsidiary, Canada Marijuana Agricorp Inc which has entered into an agreement to lease 20 acres of suitable land near Tweed, Ontario which it proposes to utilize for the commercial production of medical marijuana.

Canada Marijuana Agricorp intends to apply for a medical marijuana producer license under the new Marijuana for Medical Purposes Regulations Health Canada program, and aims to commence commercial medical marijuana growing operations as soon as its producer license is granted. The lease of the Tweed, Ontario land is for an initial term of three years with options to renew. Power for growing operations will be provided by solar energy, and a local consultant has been engaged to supervise growing operations. Plans are being formulated for the construction of greenhouses and storage facilities to facilitate year round production capabilities. The use of greenhouses will facilitate the growing of medical marijuana through hydroponic processes.

The market for medical marijuana in Canada is controlled by and subject to regulation, and the commercial medical marijuana industry is a new industry. Commencing April 1, 2014 the only legal access to marijuana for medical purposes will be through licensed producers. Health Canada anticipates that the number of Canadians authorized to consume medical marijuana is anticipated to be 450,000 by 2024.

“GreenBank’s subsidiary Canada Marijuana Agricorp intends to provide affordable, safe, regulated, high quality medical marijuana for medical marijuana patients in Canada seeking pain relief medication. We look forward to complying with all applicable Health Canada regulations as we establish commercial production of medical marijuana. The Canadian government predicts a $1.3 billion industry in 10 years and we intend to participate in this fast growing business opportunity” said Danny Wettreich, CEO of GreenBank.

GreenBank has previously announced its intention to make Bitcoin related investments through its subsidiary Bitcoin Angel Capital Inc. which is focused on investing in early stage Bitcoin and other cryptocurrency companies, and which has recently acquired 20% of Sovereign Bitcoin Exchange.

About GreenBank

GreenBank is a corporate finance investment business investing in Canadian small cap companies. GreenBank’s subsidiary Canada Marijuana Agricorp intends to be a commercial producer of medical marijuana, and GreenBank’s subsidiary Bitcoin Angel Capital is seeking to make investments in early stage Bitcoin and other cryptocurrency companies. For more information please see www.GreenBankCapitalinc.com or contact Danny Wettreich at (647) 931 9768 or dw@GreenBankCapitalinc.com.

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of GreenBank Capital Inc. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.